Table 3.

Association of serum analytes at baseline with progression-free survival

Analyte	Coefficient*	p value	q value
IL13	−2.4436	0.01876	0.58156
EGF	1.7729	0.07082	0.72256
VEGF	1.7488	0.07337	0.72256
IL6	1.6436	0.09323	0.72256
CD40LT	1.4305	0.14435	0.75366
IL1Ra	1.4279	0.14587	0.75366
MIP1b	1.1762	0.23023	0.90150
Il5	−0.1893	0.25528	0.90150
IL17	1.1078	0.26518	0.90150
MIP1a	0.9767	0.32456	0.90150
IL1a1	0.8413	0.40450	0.90150
TNFaT	−0.8156	0.40895	0.90150
IP10	−0.6095	0.42191	0.90150
IL1b1	−0.7788	0.42743	0.90150
FGFbF	0.7852	0.43621	0.90150
Tpo	−0.6656	0.48948	0.92859
IFNgIF	0.6375	0.52290	0.92859
EOTAXIN	−0.6090	0.53918	0.92859
ITAC	−0.4859	0.61549	0.98702
MIP1c	−0.4205	0.67326	0.98702
IL10	−0.3871	0.69903	0.98702
IL12p70	−0.3337	0.73799	0.98702
GMCSF	−0.2953	0.76594	0.98702
GCSF	−0.2887	0.77222	0.98702
Leptin	0.2448	0.80654	0.98702
CXCL5EN	−0.1529	0.87839	0.98702
IL4	−0.1197	0.90468	0.98702
RANTES	−0.0842	0.93282	0.98702
IL2	−0.0754	0.93869	0.98702
HGF	0.0566	0.95518	0.98702
IL8CX	0.0109	0.99129	0.99129

^*Standardized proportional hazards regression coefficient